Effect of a phenylethanolamine n-methyltransferase inhibitor, 2,3-dichloro-α-methylbenzylamine, on the alpha-2-adrenoceptor function in the hypothalamus in rats

Neuropsychobiology

Volumn 33, Issue 3, 1996, Pages 132-137

  Kubota, Masaharu ^a   Atobe, Masaru ^a   Nakagawara, Michio ^b   Kariya, Tetsuhiko ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b YOKOSUKA KYOSAI HOSPITAL   (Japan)

Author keywords

2,3 Dichloro methylbenzylamine; 3 Methoxy 4 hydroxyphenylglycol; Brain dialysis; Epinephrine; Growth hormone; Locomotor activity; Phenylethanolamine N methyltransferase inhibitors

Indexed keywords

2,3 DICHLORO ALPHA METHYLBENZYLAMINE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; GROWTH HORMONE; NORADRENALIN;

ARTICLE; CONTROLLED STUDY; DIALYSATE; GROWTH HORMONE RELEASE; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BENZYLAMINES; ENZYME INHIBITORS; HYPOTHALAMUS; LOCOMOTION; MALE; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; TIME FACTORS;

EID: 0029922670     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119263     Document Type: Article

References (48)

1. DeQuattro V, Nagatsu T, Maronde R, Alexander M: Catecholamine synthesis in rabbits with neurogenic hypertension, Circ Res 1969;24: 545-559.
2. Nakagawara M: The effects of phcnylethanol-amine-N-methyltransferasc inhibitor on locomotor activity in rats; in Bunney WE Jr., Hip-pius H, Laakmann G, Schmauss M (eds); Neuro psychopharmacology, Berlin, Springer, 1990, pp 277-285.
3. Reis DJ: Brain-stem mechanisms governing resting and reflex tone of precapillary vessels, J Cardiovasc Pharmacol 1985;7;s160-s166.
4. Terry LC: Regulation of anterior pituitary hormone secretion by brain epinephrine; in Stork JM, U Prichard DC, Fuxe K (eds): Epinephrine in the Central Nervous System, New York, Oxford University Press, 1988, pp 154-163.
5. Toomey RE, Horng JS, Hemrick-Lueckc SK, Fuller RW: Alpha-2-adrcnoceptor affinity of some inhibitors of norepinephrine N-methyl-transfcrase, Life Sci 1981;29:2467-2472.
6. Christensen NJ, Vestcrgaard T, Sorensen T, Rafaelscn OJ: Cerebrospinal fluid adrenaline and noradrenaline in depressed patients, Acta Psychiatr Scand 1980:61:178-182.
7. Gjerris A, Rafaelscn OJ, Christensen NJ: CSF-adrenaline - low in somatiz.ing depression, Acta Psychiatr Scand 1987;75:516-520.
8. Matussck N: Catecholamines and mood, Curr Top Ncuroendocrinol 1988;8:141-182.
9. Laakmann G: Psycho pharmacon euroendocrinology and Depression Research, Berlin, Springer, 1988, pp 163-207.
10. Black J, Wacbar B, Bresnahan MR, Gavras I, Gavras H: Blood pressure response to central and/or peripheral inhibitor of phenylethanol-amine-N-methyltransfcrase in normotensive and hypertensive rats, Circ Res 1981:49:518-524.
11. Kubota M, Nakagawara M, Atobe M: Effects of ipsapirone on noradrenergic function in the rat brain (in Japanese), Annu Rep Pharmacopsy-chiatr Res Fund 1993:24:55-59.
12. Fuller RW: Pharmacology of brain epinephrine neurons, Annu Rev Pharmacol Toxicol 1982: 22:31-55.
13. Malta SG, Singh J, Sharp BM: Catecholamines mediate nicotine-induced adrenocorticotropin secretion via u-adrenergic receptors, Endocrinology 1990:127:1646-1655.
14. Lang WJ, Lambert GA, Rush ML: The role of the central nervous system in the cardiovascular responses to yohimbine, Arch Int Pharma-codyr.Thér 1975;217:57-67.
15. Browne RG: Anxiolytics antagonize yohimbine's discriminative stimulus properties, Psy-chopharmacotogy 1981;74:245-249.
16. Gentsch C, Lichtstciner L, Feer H: Behavioral effects of yohimbine and chlordiazepoxidc: Dependence on the rat’s previous familiarization with the test conditions, Neuropsychobiology 1989;22:101-107.
17. Drew GM, Gower AJ, Marriott AS: Adrenoceptors mediate clonidine-induced sedation in the rat, BrJ Pharmacol 1979;67:133-141.
18. Ortmann R, Mutter M, Delini-Stula A: Effect of yohimbine anti itsdiastercoisomcrsoncloni-dinc-induced depression of exploration in the rat, Eur J Pharmacol 1982:77:335-337.
19. Putkonen PTS, Leppavuori A, Stenberg D: Paradoxical sleep inhibition by central alpha-adrcnoccplor stimulant clonidine antagonized by alpha-reccptor blocker yohimbine, Life Sci 1977;21:1059-1066.
20. Hsu WH: Xylazine-induccd depression and its antagonism by alpha blocking drugs, J Pharmacol Exp Ther 1981;218:188-192.
21. Summners C, DeVries JB, Dijkstra D, Horn AS: Involvement of both dopaminergic and a-adrenergic receptors in the hypomobility induced by dibenzoyl-6,7-ADTN, Eur J Pharmacol 1981;70:541-550.
22. Starke K: Presynaptic receptors, Annu Rev Pharmacol Toxicol 1981:21:7-30.
23. Roth RH: Neuronal activity, impulse flow and MHPG production; in Mass JW (ed): MHPG: Basic Mechanisms and Psychopathology, New York, Academic Press, 1983, pp 19-31.
24. Abercrombie ED, Keller RW Jr., Zigmond MJ: Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion, Neuroscience 1988:27:897-904.
25. Szemeredi K, Komoly S, Kopin IJ, Bagdy G, Keister HR, Goldstein DS: Simultaneous measurement of plasma and brain extracellular fluid concentrations of catechols after yohimbine administration in rats, Brain Res 1991; 542:8-14.
26. Pacak K, Yadid G, Jakab G, Lenders JWM, Kopin IJ, Goldstein DS: In vivo hypothalamic release and synthesis of catecholamines in spontaneously hypertensive rats, Hypertension 1993;22:467-478.
27. Fuller RW, Perry KW: Lowering of epinephrine concentration in rat brain by 2,3-dichloro-alpha-methylbenzylamine, an inhibitor of norepinephrine N-methyltransferase, Biochem Pharmacol 1977:26:2087-2090.
28. Liang NY, Hower JA, Borchardt RT: Effects of phcnylethanolaminc N-mcthyltransferase inhibitors on uptake and release of norepinephrine and dopamine from rat brain, Res Com-mun Chem Pathol Pharmacol 1985:49:467-470.
29. Gunnc LM: Relative adrenaline content in brain tissue, Acta Physiol Scand 1962:56:324-333.
30. Grealy M, O’Donnell JM: Secretion of growth hormone elicited by intravenous desipramine in the conscious, unrestrained rat, Br J Pharmacol 1991;102:369-372.
31. Bousquet P, Feldman J, Tibirica E, Bricca G, Molines A, Dontenwill M, Belcourt A: New concepts on the central regulation of blood pressure: Alpha-2-adrenoceptors and 'imidazoline receptors’, Am J Med 1989:87:10s-13s.
32. Kiem DT, Bartha L, Harsing LG Jr., Makara GB: Réévaluation of the role of co-adrenoceptors in morphine-stimulated release of growth hormone, Neurocndocrinology 1991:53:516-522.
33. Krulich L, Mayfield MA, Steele MK, McMillcn BA, McCann SM, Koenig JI: Differential effects of pharmacological manipulations of ccn-iral alpha-1 and alpha-2 adrenergic receptors on the secretion of thyrotropin and growth hormone in male rats, Endocrinology 1982:110: 796-804.
34. Laakmann G, Zygan K, Schoen HW, Weiss A, Wittmann M, Mcissner R, Blachke D: Effect of receptor blockers on desipramine induced pituitary hormone stimulation in humans, 1, Growth hormone, Psychoneuroendocrinology 1986;11:447-461.
35. Cozzi MG, Zanini A, Locatelli V, Celia SG, Muller EE: Growth hormone-releasing hormone and clonidine stimulate biosynthesis of growth hormone in neonatal pituitaries, Bio-phys Res Commun 1986:138:1223-1230.
36. Macrtcns P, Denef C: Alpha-adrenergic stimulation of growth hormone release in perfused rat anterior pituitary reaggregate cell cultures, Mol Cell Endocrinol 1987;54:203-211.
37. Bcrthcrat J, Bluet-Pajot MT, Epelbaum J: Neuroendocrine regulation of growth hormone, Eur J Endocrinol 1995;132:12-24.
38. Devesa J, Diaz MJ, Tresuerras JAF, Arce V, Lima L: Evidence that alpha-2-adrencrgic pathways play a major role in growth hormone neuroregulation, J Clin Endocrinol Metab 1991;73:251-256.
39. Eden S, Eriksson E, Martin JB, Modigh K: Evidence for a growth hormone releasing factor mediating alpha-adrenergic influence in growth hormone secretion in rat, Ncuroendo-crinology 1981:33:24-27.
40. Kabayama Y, Kato Y, Murakami Y, Tanaka H: Stimulation by alpha adrenergic mechanisms of the secretion of growth hormone releasing factor from perfused rat hypothalamus, Endocrinology 1986:119:432-434.
41. Lima L, Arce V, Trcsgucrrcs JA, Devesa J: Clonidine potentiates the GH response to GH releasing hormone in norepinephrine synthesis inhibited rats: Evidence for an alpha-2-adrcn-ergic control of hypothalamic release of somatostatin, Neuroendocrinology 1993,57: 1155-1160.
42. Lima I-, Arce V, Tresguerres JA, Devesa J: Studies on alpha-2-adrenergic somatostatin modulation secretion in rats, Life Sci 1993:53: 665-668.
43. Miki N, Ono M, Shizume K: Evidence that opiatcrgic and alpha-adrenergic mechanisms stimulate rat growth hormone release via growth hormone-releasing factor, Endocrinology 1984:114:1950-1952.
44. Terry LC, Martin JB: The effects of lateral hypothalamic-medial forebrain stimulation and somatostatin antiscrum on pulsatile growth hormone secretion in freely behaving rats, Endocrinology 1981;109:622-627.
45. U’Prichard DC: Biochemical characteristics and regulation of brain alpha-2-adrcnoceptors, Ann N Y Acad Sci 1984:430:55-75.
46. Amsterdam JD, Maislin G, Skolnick B, Wino-kur A: Multiple hormone responses to clonidine administration in depressed patients and healthy volunteers, Biol Psychiatry 1989:26: 265-278.
47. Schittccattc M, Charles G, Machowsky R, Wil-motte J: Growth hormone response to clonidine in untreated depressed patients, Psychiatry Res 1989:29:199-206.
48. Sievcr LJ, Trcstman RJ, Coccaro EF, Bernstein D, Gabriel SM, Owen K, Moran M, Lawrence T, Rosenthal J, Horvath TB: The growth hormone response to clonidine in acute and remitted depressed male patients, Neuropsycho pharmacology 1992:6:165-177.